Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
ImmunityBio, Inc.
H. Lee Moffitt Cancer Center and Research Institute
University of Oklahoma
Exelixis
Medical College of Wisconsin
Universitaire Ziekenhuizen KU Leuven